or Try an Advanced Search...

    Bristol Myers Squibb Stocks List

    Symbol Grade Name % Change
    BMY F Bristol-Myers Squibb Company 0.61
    CTMX B CytomX Therapeutics, Inc. 214.72
    RAPT F RAPT Therapeutics, Inc. 6.23
    SNY A Sanofi 1.63
    TSVT D 2seventy bio, Inc. 0.88
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Life Sciences Cancer Biopharmaceutical Hypertension Multiple Myeloma Animal Health Atrial Fibrillation Biopharmaceutical Products Biotechnology Breakthrough Therapy Cac 40 Cancer Treatment Chimeric Antigen Receptor T Cell Chronic Kidney Disease Chronic Myeloid Leukemia Clinic Clopidogrel Colorectal Cancer Compugen Consumer Health Care

    Related ETFs - A few ETFs which own one or more of the above listed Bristol Myers Squibb stocks.

    Symbol Grade Name Weight
    PPH B Market Vectors Pharmaceutical ETF 8.89
    FTXH C First Trust Nasdaq Pharmaceuticals ETF 7.38
    MEDX F Horizon Kinetics Medical ETF 5.43
    WBIY C WBI Power Factor High Dividend ETF 4.72
    XPH D SPDR S&P Pharmaceuticals ETF 4.47
    View all Bristol Myers Squibb ETFs...
    Compare ETFs
    Compare FTXH to MEDX Compare FTXH to WBIY Compare MEDX to WBIY

        Bristol Myers Squibb Stocks Recent News

        Date Stock Title
        May 1 BMY Editas, Bristol Myers extend T cell therapy collaboration
        May 1 CTMX CytomX surges on upcoming data for Amgen-partnered cancer drug
        May 1 CTMX CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clinical Data Update on May 8, 2024
        May 1 BMY Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration
        Apr 30 SNY Sanofi (NASDAQ:SNY) Q1 2024 Earnings Call Transcript
        Apr 30 SNY Press Release: Annual General Meeting of April 30, 2024
        Apr 30 SNY Sanofi: Q1 Earnings Reflect Growth And Strategic Acquisitions (Rating Upgrade)
        Apr 30 BMY Bristol-Myers Squibb Company (NYSE:BMY) Q1 2024 Earnings Call Transcript
        Apr 30 BMY J&J, Bristol Myers latest to lose bids to halt Medicare price negotiations
        Apr 30 BMY Bristol Myers Squibb: Tough Times Continue
        Apr 29 BMY J&J, Bristol Myers lose challenges to US drug price negotiation program
        Apr 29 BMY Bristol Myers, Repertoire to develop tolerizing vaccines in multi-year pact
        Apr 29 BMY Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases
        Apr 29 BMY Repertoire pivot pays dividends with Bristol Myers deal
        Apr 29 BMY Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
        Apr 29 SNY Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
        Apr 28 BMY Last Week's Worst-Performing Stocks: Are These 10 Large-Cap Stocks In Your Portfolio? (April 21-27, 2024)
        Apr 27 BMY Bristol-Myers Squibb First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        Apr 26 BMY Bristol, Sanofi, Takeda gain positive CHMP recommendations
        Apr 26 SNY Bristol, Sanofi, Takeda gain positive CHMP recommendations
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Life Sciences Cancer Biopharmaceutical Hypertension Multiple Myeloma Animal Health Atrial Fibrillation Biopharmaceutical Products Biotechnology Breakthrough Therapy Cac 40 Cancer Treatment Chimeric Antigen Receptor T Cell Chronic Kidney Disease Chronic Myeloid Leukemia Clinic Clopidogrel Colorectal Cancer Compugen Consumer Health Care
        Bristol Myers Squibb

        Bristol-Myers Squibb Company (BMS) is an American pharmaceutical company, headquartered in New York City.
        Bristol-Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders.
        BMS' primary R&D sites are located in Lawrence, New Jersey (formerly Squibb, near Princeton) and Wallingford, Connecticut (formerly Bristol-Myers); with other sites in East Syracuse, New York; Princeton Pike, Hopewell Township and New Brunswick, New Jersey; and in Swords, Ireland; Braine-l'Alleud, Belgium; Tokyo, Japan; and Bangalore, India.

        More about Bristol Myers Squibb
        Browse All Tags